Congress’ most influential health panels will see dramatic changes next year, with several advocates on specific issues like mental health, Medicare and drug pricing retiring or losing their reelection bids.
The biggest changes will be in store at the House Energy and Commerce Committee, whose wide-ranging jurisdiction includes health insurance, biomedical research, and drug and device safety.
Five of the 12 Democrats on the Health Subcommittee will not be returning: Ranking member Anna G. Eshoo of California and Reps. John Sarbanes of Maryland, Tony Cárdenas of California and Ann McLane Kuster of New Hampshire did not seek reelection this year. And Rep. Lisa Blunt Rochester of Delaware was elected to the Senate.
